From cancer vaccines to engineered T cells, experts weigh in on the big unknowns
March 18, 2016
| by Susan Keown / Fred Hutch News Service
Fred Hutch immunotherapy experts share their perspectives on a few of the big questions in cancer immunotherapy research — and the steps that they and their colleagues are taking to answer them as quickly as they can.
Researchers design and create donut-shaped proteins from scratch
Dec. 16, 2015
| By Dr. Rachel Tompa / Fred Hutch News Service
Researchers design and create donut-shaped proteins from scratch that could one day help yield more potent vaccines, more powerful growth factors to stimulate the growth of cancer-fighting immune cells in stem cell or cord blood transplants, or even a molecular sponge to soak up toxins in the body after poisoning.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.